Abstract
The first intragastric balloon was launched in the market 30 years ago. From then, different intragastric prosthesis have been presented and used worldwide. There are, now, one billion overweight/obese persons worldwide. Only some of those patients express the desire or are able to undergo surgical operation. At present there is no medical cure for obesity. Despite the numerous dietary treatments, the natural course of obesity is characterized by an ongoing and sometimes unstoppable weight gain. In patients with first degree obesity, the intragastric balloon interrupts the ongoing and inexorable weight gain, and improves the relevant co-morbidities. In super-obese patients, where there are numerous co-morbidities, the weight loss obtained with the balloon represents a chance to reduce the surgical and anesthesiologic complications deriving from bariatric surgery.
Different balloons (filled with fluids, gas or air) are present in the market, but the BioEnterics® Intragastric Balloon (BIB) is still the most used and known. Therefore, the chapter is mainly focused on it. However in some patients, especially overweight patients, there is doubt on the placement due to the post-placement discomfort. The Obalon® Gastric Balloons (OBG) (Obalon Therapeutics, Carlsbad, California) is a fully repeatable and reversible intragastric balloon; compared to other balloons it is totally swallowable, does not need endoscopy for its placement and has low rate of post-placement symptoms.
The chapter explores the history of intragastric balloons, the indications, technical notes and complications of intragastric balloon treatment with particular attention to the state-of-the-art long term results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ogunnaike BO, Jones SB, Jones DB, Provost D, Whitten CW. Anesthetic considerations for bariatric surgery. Anesth Analg. 2002;95(6):1793–805.
ASGE Technology Committee, Kethu SR, Banerjee S, Barth BA, Desilets DJ, Kaul V, et al. Endoluminal bariatric techniques. Gastrointest Endosc. 2012;76(1):1–7.
Majumder S, Birk J. A review of the current status of endoluminal therapy as a primary approach to obesity management. Surg Endosc. 2013;27(7):2305–11.
Pasulka PS, Bistrian BR, Benotti PN, Blackburn GL. The risks of surgery in obese patients. Ann Intern Med. 1986;104(4):540–6.
Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18(12):1611–7.
Alfredo G, Roberta M, Massimiliano C, Michele L, Nicola B, Adriano R. Long-term multiple intragastric balloon treatment—a new strategy to treat morbid obese patients refusing surgery: prospective 6-year follow-up study. Surg Obes Relat Dis. 2014;10(2):307–11.
Tai CM, Lin HY, Yen YC, Huang CK, Hsu WL, Huang YW, et al. Effectiveness of intragastric balloon treatment for obese patients: one-year follow-up after balloon removal. Obes Surg. 2013;23(12):2068–74.
Mathus-Vliegen EMH, Eichenberger RI. Fasting and meal-suppressed Ghrelin levels before and after intragastric balloons and balloon-induced weight loss. Obes Surg. 2014;24:85–94.
Genco A, Bruni T, Doldi SB, Forestieri P, Marino M, Busetto L, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15(8):1161–4.
Genco A, Balducci S, Bacci V, Materia A, Cipriano M, Baglio G, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg. 2008;18(8):989–92.
Dogan U, Gumurdulu Y, Salih Akin M, Yalaki S. Five percent weight lost in the first month of intragastric balloon treatment may be a predictor for long-term weight maintenance. Obes Surg. 2013;23:892–6.
Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22:896–903.
Busetto L, Tregnaghi A, De Marchi F, Segato G, Foletto M, Sergi G, et al. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res. 2002;10(5):408–11.
Genco A, Lorenzo M, Baglio G, Furbetta F, Rossi A, Lucchese M, et al. Does the intragastric balloon have a predictive role in subsequent LAP-BAND(®) surgery? Italian multicenter study results at 5-Year follow-up. Surg Obes Relat Dis. 2014;10(3):474–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Video 50.1
BIB placement and removal technique. In particular the removal technique is shown in its two variants: using dedicated devices (balloon grasper) and using endoscopic equipments usually available in every endoscopic department (needle and polypectomy snare) (WMV 1740 kb)
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Genco, A., Maselli, R., Casella, G., Cipriano, M., Redler, A. (2016). Intragastric Balloon Treatment for Obesity. In: Agrawal, S. (eds) Obesity, Bariatric and Metabolic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-04343-2_50
Download citation
DOI: https://doi.org/10.1007/978-3-319-04343-2_50
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-04342-5
Online ISBN: 978-3-319-04343-2
eBook Packages: MedicineMedicine (R0)